Asiri Surgical Hospital PLC

AMSL.N0000

Healthcare · Hospital/Nursing Management

Rs 14.00
+0.00%
as of Aug 3, 2026
Price history
+3.70%
P/E
9.0
P/B
0.94
EPS
Rs 1.56
Div Yield
0.00%
Market Cap
Rs 7.4B
Beta
1.26
ROE
4.1%
Op Margin
15.0%

Annual fundamentals

YearRevenueNet profitEPS
2025Rs 7.2BRs 373.7M0.50
2024Rs 6.6BRs 746.3M1.24
2023Rs 5.6BRs 640.0M1.21
2022Rs 5.8BRs 1.2B2.36
2021Rs 4.2BRs 859.7M1.63
2020Rs 3.7BRs 433.1M0.82
2019Rs 3.5BRs 366.5M0.69

Recent dividends

  • 2025 · first interimRs 0.30
  • 2022 · second interimRs 0.90
  • 2022 · first interimRs 1.20
  • 2021 · second interimRs 0.60
  • 2021 · first interimRs 0.25
  • 2019Rs 0.50
  • 2018Rs 0.85
  • 2017Rs 0.35

About Asiri Surgical Hospital PLC

Asiri Surgical Hospital (ASH) is a private sector surgical hospital in Sri Lanka offering a broad range of surgical disciplines from routine procedures to complex surgeries. The hospital operates 155+ beds, records over 200,000 channellings and performs 8,800+ surgeries, delivering care through state-of-the-art operating theatres, advanced diagnostic facilities and modern medical technology. ASH provides end-to-end surgical care spanning pre-surgical consultations and diagnostic evaluations through personalised post-operative care, supported by stringent protocols for infection control and patient safety. The hospital emphasises continual investment in new medical technologies and surgical techniques to maintain clinical standards. The organisation highlights several centres of excellence, including cardiology, oncology, orthopedics, urology, neurology, gastroenterology and organ transplantation. The wider Asiri Hospital Holdings group describes group-level environmental and social initiatives such as waste management, energy-efficiency upgrades and community outreach programs.

AI analysis

neutral

Profitability has rebuilt, with the latest quarter’s net margin at 13.4%, yet the share trades near book at P/B 0.94 after a -46.0% three-month slide.

Read the full report (Aug 4, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

No scored news in the last 30 days.

24 months positive negative 3-month net
Jul 25: 2 articles, net +0.50Sep 25: 3 articles, net -0.46Mar 26: 2 articles, net -1.00Jun 26: 1 articles, net +1.00Jul 24Nov 24Mar 25Jul 25Nov 25Mar 26
Recent news
View all news →
Daily FT·Sep 2, 2025·Management or board change
Imran Furkan joins Softlogic Holdings Board

Softlogic Holdings PLC appointed Imran Furkan as an Independent Non-Executive Director effective 29 August 2025. Furkan, CEO of Tresync (Australia), has prior board roles including at Odel, Asiri Surgical Hospital and Maharaja Foods and experience across health, retail and IT.

Healthcare & PharmaIT & Digital

Healthcare sector: what is happening

Last 30 days to Aug 4, 2026

SLPMA dominated sector news, urging a long-term government buyback to back local pharma manufacturing, quicker raw-material import approvals and stable incentives, plus a national push to make pharmaceuticals an export engine through a task force and faster regulation. Cross-border activity featured a 31-member Indian delegation on 8-10 July for B2B sessions including pharma. Colombo Port City moved to seek operators for an international hospital. Cybersecurity risks to hospitals gained attention.

Auto-generated from 8 sector news articles over 30 days. Not investment advice. 2 more stories on the sentiment page.